$CLMT

Calumet Provides Update After Latest U.S. EPA Small Refinery Exemption Decision

Calumet, Inc. (CLMT) received full exemptions from the EPA for two small refinery petitions, reducing its RIN liability by 71 million RINs valued at $170 million. The remaining liability is 129 million RINs worth $309 million, pending further EPA discussions and legal reviews. Calumet operates in specialty products and renewable fuels.

Original reporting
Published Sep 2, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 1:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefRegulation
Primary signal
$CLMT
Bullish
high confidence
Mentioned
$CLMT
Relevance
8/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$CLMTBullishHigh
01

Why it matters

The exemption removes $170M of RIN liability, improving cash flow and reducing risk exposure.

02

Market read

Regulatory relief for Calumet could lift its stock and set a precedent for peers.

03

What to watch

Potential litigation from competitors challenging the exemptions.

Relevance 8/10Novelty 8/10Timing: today

Background

Calumet is a diversified specialty fuels and renewable fuel producer with twelve North American facilities.

Company-level read

Ticker impact

$CLMTBullishHigh confidence
Context

Calumet announced EPA granted full exemptions on two small refinery petitions, cutting $170M of RIN liability.

Expected impact

Potential upside of several percent as investors re‑rate the company.

Evidence & confidence

The $170M liability reduction is material for a mid‑cap specialty fuels producer and is disclosed for the first time.

Market effects

Other small‑refinery operators may see similar EPA exemption requests, affecting the renewable fuels sector.

U.S. renewable fuel market could see tighter RIN pricing pressure.

Limited to U.S. regulated fuel producers.

Counterpoint

If EPA later revokes exemptions, liability could rebound, pressuring the stock.

Key entities

  • Calumet, Inc.

    Issuer of the press release and subject of the EPA exemption.

  • U.S. Environmental Protection Agency

    Granted the small refinery exemptions.

Related articles

$CLMTHighAI 8/10

Calumet reports Q2 EPS ($1.09) vs. ($1.70) last year

Calumet Specialty Products Partners (CLMT) reported Q2 EPS of ($1.09), an improvement from ($1.70) last year. Revenue rose to $1.45B from $1.03B. CEO Todd Borgmann highlighted strong margin performance and debt reduction. The company's Montana Renewables unit completed the first phase of a fuel expansion project.

$CLMTMed

Calumet stock hits 52-week high at 54.72 USD

Calumet Specialty Products Partners (CLMT) hit a 52-week high of $54.72, up 205.27% over the past year. The company reported Q2 2026 revenue of $1.44B, beating estimates, but missed earnings expectations. S&P upgraded its credit rating to 'B-', while UBS and TD Cowen raised price targets to $47 and $40, respectively, with Neutral/Hold ratings.

$CLMTMed

Q2 Earnings Highlights: Calumet (NASDAQ:CLMT) Vs The Rest Of The Infrastructure Stocks

Calumet (CLMT) stock rose 8.9% post-earnings, trading at $16.19. Kodiak Gas Services (KGS) reported $391.1M revenue, up 21.1% YoY, with stock up 10.5% to $62.81. Excelerate Energy (EE) saw $329.3M revenue, up 61% YoY, with stock up 3% to $39.65. DHT Holdings (DHT) reported $255.2M revenue, up 174% YoY, with stock up 13% to $20.19. Market focus has shifted from AI to geopolitics and back to fundamentals.

$CLMTMed

Why Calumet Stock Topped the Market Today

Calumet (CLMT) stock rose 3% after the EPA granted full exemptions for two refineries, removing 71 million RINs from its balance sheet. The company values remaining RINs at $309 million. Calumet is also seeking exemptions for 2022-2024, which are under review. The exemptions improve its financials by reducing compliance costs.